CD79A and autoimmune polyendocrinopathy: In contrast to IgG and IgM aCL/aβ2GPI, IgA antibodies are not included in the current APS criteria as the role of IgA aCL and aβ2GPI in APS was, and still is, not clear [36,44,118,173,174,175].